Objective The PROMEMORIA project focuses on the role of cell recognition processes in normal and dysfunctional plasticity, learning and memory with the aim of developing compounds with a beneficial effect on diseases involving cognitive impairment. The consortium expects to discover new genes and proteins, identify novel pathogenic mechanisms and define new therapeutic strategies. This is highly relevant to the objectives of thecall: LSH-2003-2.1.3-2. The consortium consists of 18 leading teams from 11 countries, of which two are new EU-member states. It is composed of 14 academic partners and 4 SMEs. The partners cover a wide range of expertises and technical competencies required to address in an ambitious manner the full scope of the call. Thus, the consortium contains teams specialized in genetics, protein chemistry, neurophysiology, neuroanatomy, neurobiology, animal models of learning and behaviour, in vivo test systems for a very broad range of behaviour and learning phenomena. Moreover, there is a considerable expertise in drug screening and development. The proposal presents a series of subprojects focused on gene discovery, structural biology, synaptic plasticity at both the physiological and morphological level, and a number of models of deficient plasticity, learning and memory. Moreover, the focus of the project, neuronal cell adhesion molecules, is novel and unique. Recent research has shown that these molecules play key roles in learning and memory. They have a very broad distribution in the nervous system for which reason they are optimal targets for drug development. An efficient dynamic management structure is proposed with four key objectives: Integration of research results and early identification of new findings; training of future world leaders in this research area; dissemination of results to scientists, patients and the general public; the issue of 5-10 patents securing protection and transfer to European industry of PROMEMORIA discoveries. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverymedical and health sciencesbasic medicineneurologydementiaalzheimernatural sciencesbiological sciencescell biologymedical and health sciencesbasic medicinepharmacology and pharmacypharmacokineticsmedical and health sciencesbasic medicinetoxicology Keywords Genetics cell adhesion molecules cognition dementia dementian drug development eurodegeneration neurodegeneration Programme(s) FP6-LIFESCIHEALTH - Life sciences, genomics and biotechnology for health: Thematic Priority 1 under the Focusing and Integrating Community Research programme 2002-2006. Topic(s) LSH-2003-2.1.3-3 - Molecular mechanisms of neuronal degeneration LSH-2003-2.1.3-2 - Neuronal networks, learning and memory: from genes to behaviour Call for proposal FP6-2003-LIFESCIHEALTH-I See other projects for this call Funding Scheme IP - Integrated Project Coordinator UNIVERSITY OF COPENHAGEN Address Nørregade 10 2177 Copenhagen Denmark See on map Links Website Opens in new window EU contribution No data Participants (17) Sort alphabetically Sort by EU Contribution Expand all Collapse all THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN Ireland EU contribution € 0,00 Address College green Dublin See on map Other funding No data INSTITUTE OF NEUROLOGY - UNIVERSITY COLLEGE LONDON United Kingdom EU contribution € 0,00 Address Queen square London See on map Links Website Opens in new window Other funding No data CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE France EU contribution € 0,00 Address 3 rue michel-ange Paris See on map Links Website Opens in new window Other funding No data NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITÄT TÜBINGEN Germany EU contribution € 0,00 Address Markwiesenstr. 55 Reutlingen See on map Links Website Opens in new window Other funding No data UNIVERSITY OF GENEVA, MEDICAL FACULTY Switzerland EU contribution € 0,00 Address 1, m.servet Geneva See on map Links Website Opens in new window Other funding No data THE OPEN UNIVERSITY United Kingdom EU contribution € 0,00 Address Wallton hall Milton keynes See on map Links Website Opens in new window Other funding No data CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS ORGANIZATION Spain EU contribution € 0,00 Address Serrano 117 Madrid See on map Links Website Opens in new window Other funding No data MEDIZINISCHE HOCHSCHULE HANNOVER Germany EU contribution € 0,00 Address Carl-neuberg-str. 1 Hannover See on map Links Website Opens in new window Other funding No data INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY Poland EU contribution € 0,00 Address Ks.trojdena str. 4 Warsaw See on map Links Website Opens in new window Other funding No data LUND UNIVERSITY Sweden EU contribution € 0,00 Address Paradisgatan 5c 117 Lund See on map Links Website Opens in new window Other funding No data ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE Switzerland EU contribution € 0,00 Address Ecublans Lausanne See on map Links Website Opens in new window Other funding No data UNIVERSITY OF HAIFA Israel EU contribution € 0,00 Address Mount carmel Haîfa See on map Other funding No data ENKAM PHARMACEUTICALS A/S Denmark EU contribution € 0,00 Address Fruebjergvej 3 Copenhagen See on map Links Website Opens in new window Other funding No data NEUROPHARMA S.A.U. Spain EU contribution € 0,00 Address Avenida de la industria 52 Tres cantos (madrid) See on map Links Website Opens in new window Other funding No data REGLIA AB Sweden EU contribution € 0,00 Address Stena center 1d Göteborg See on map Other funding No data SCHAFER-N Denmark EU contribution € 0,00 Address Lersø park álle 42.6 Copenhagen See on map Links Website Opens in new window Other funding No data UNIVERSITY OF TARTU Estonia EU contribution € 0,00 Address 18 ylikooli street Tartu See on map Links Website Opens in new window Other funding No data